Market Overview
The Global
Biopharma Plastics Market was reached
USD 5,695.3 million in 2023 and is expected to reach
USD 18,130.3 million in 2033 while
having a CAGR of 12.4% during the forecast period.
Biopharma plastics provide various advantages, making them the perfect option for several healthcare uses. Their low chemical reactivity, high resistivity, & good thermal stability make them the preferred materials for the production of products like containers, syringes, bioreactor bags & disposable connectors. These polymers’ versatility & their ability to serve various needs in the
healthcare industry have resulted in their enhanced adoption, further boosting the biopharma plastics market.
Key Takeaways
- Market Growth: The Biopharma Plastics Market size is expected to grow by 11.179.0 million, at a CAGR of 12.4% during the forecasted period of 2025 to 2033.
- By Polymer Type: The PVC (Polyvinyl chloride) segment as s polymer is expected to lead in 2024 with a major & is anticipated to dominate throughout the forecasted period.
- By Application: Syringes are expected to get the largest revenue share in 2024 in the Biopharma Plastics market.
- Regional Insight: Asia Pacific is expected to hold a 31.1% share of revenue in the Global Biopharma Plastics Market in 2024.
- Use Cases: Some of the use cases of Biopharma Plastics include Lab Equipment, Packaging Solutions, and more.
Use Cases
- Medical Device Manufacturing: Biopharma plastics are used to develop many medical devices like syringes, IV bags, and tubing, providing necessary sterility and biocompatibility.
- Packaging Solutions: These plastics are important for packaging pharmaceuticals, ensuring product safety, maintaining sterility, and extending shelf life.
- Lab Equipment: Biopharma plastics are used in the production of laboratory equipment like Petri dishes, pipettes, and centrifuge tubes, which need high levels of cleanliness and precision.
- Drug Delivery Systems: They are used in drug delivery mechanisms, like controlled-release capsules and implants, to ensure proper dosage and effective delivery of medication to patients.
Market Dynamic
Driving Factors
Rising Demand for BiopharmaceuticalsThe growing global demand for biopharmaceutical products, like vaccines, monoclonal antibodies, and other biologics, is driving the need for high-quality, sterile, and biocompatible plastic materials used in manufacturing, packaging, and delivery systems.
Technological AdvancementsInnovations in plastic materials & manufacturing technologies, like the development of new biocompatible and biodegradable plastics, are improving the performance and sustainability of
biopharma plastics, making them more attractive to the industry and driving market growth.
Restraints
Regulatory ChallengesStrict regulatory requirements and approval processes for medical-grade plastics can impact the development and commercialization of new plastic materials, slowing down market growth.
Environmental ConcernsHigher scrutiny and regulations regarding the environmental impact of plastic waste, mainly in medical and biopharmaceutical applications, create challenges for the market, demanding the development and adoption of more sustainable and
biodegradable plastic options.
Opportunities
Development of Sustainable PlasticsThe growing focus on environmental sustainability provides an opportunity for the development and adoption of biodegradable and recyclable biopharma plastics, meeting regulatory needs and consumer demand for eco-friendly solutions.
Expansion in Emerging Markets
Higher healthcare infrastructure and pharmaceutical manufacturing capabilities in emerging markets provide major growth opportunities for biopharma plastics, as these regions need more medical devices, packaging solutions, and drug delivery systems.
Trends
Integration of Advanced Manufacturing Technologies
The adoption of advanced manufacturing technologies like 3D printing and micro-molding is on the growth. These technologies allow the production of highly accurate and customized medical devices and components, enhancing efficiency & broadening the scope of applications for biopharma plastics.
Increased Focus on Smart and Functional Plastics
There is a major trend towards the use of smart & functional plastics in biopharma applications. These materials can have additional properties like antimicrobial effects, UV protection, or temperature sensitivity, improving the performance and safety of medical devices and packaging solutions.
Research Scope and Analysis
By Polymer Type
The global biopharma plastics market is set to be dominated by PVC (Polyvinyl chloride), which will account for the maximum share in 2024. Polyvinyl chloride’s broad usage can be due to its capability to undergo various processes without cracking or breaking, making it more versatile in several applications.
Its exceptional resistance, flexibility, & ability to resist higher temperatures make it the most preferred choice for manufacturing disposable connectors, syringes, depth filters, & other biopharma plastic applications. Biopharmaceutical plastic polymers have gained major popularity due to their capacity to provide a smooth, long-lasting surface that is resistant to UV & chemical exposure.
These polymers also show remarkable resistance to oxidation, together with water repellency & vapor permeability, creating strong, eco-friendly, & economical final items. Biopharmaceutical plastic materials, which naturally repel water, are now being used in healthcare for protective clothing.
Furthermore, large manufacturing facilities & a robust industry are driving this growth. In addition, plastics like polytetrafluoroethylene & polyethylene are famous due to their appearance, durability, & resistance to cleaning agents, further leading to market expansion in the coming future.
By Application
Syringes will dominate the biopharma plastics market, accounting for the maximum share in 2024. The prefilled syringes market is expected to observe major growth because of many factors like their affordable, convenience, low injection errors, lower microbial contamination, & dilution errors, leading to enhanced demand.
The growth of this segment can be due to the growth in acceptance of developed technologies for healthcare & medicine, the rise in production of large molecules, & the growth in spending in such advanced healthcare facilities. One-time-use biopharma plastic syringes provide ease of use & convenience, causing their enhanced popularity in the market. Moreover, the existence of properly developed healthcare infrastructure in different nations further grows the demand for these devices, consequently boosting the need for biopharma plastics used in their manufacturing. The constant growth in demand for prefilled syringes, driven by their usage convenience, and affordable, is expected to positively impact the growth of the syringes segment in the biopharma plastics sector for the period.
The Biopharma Plastics Market Report is segmented on the basis of the following
By Polymer Type
- Polyethylene (PE)
- Polypropylene (PP)
- Polyethylene Terephthalate (PET)
- Polyvinyl Chloride (PVC)
- Acrylonitrile Butadiene Styrene (ABS)
- Polycarbonate (PC)
- Others
By Application
- Containers
- Bioreactor Bags
- Protective Wear
- Depth Filters
- Syringes
- Disposable Medical Connectors
- Others
Regional Analysis
The Asia Pacific region is expected to come out as the dominant place biopharma plastics market, with an anticipated maximum
share of 31.1% of total revenue, in 2024. In Asia-Pacific, China leads the biopharma plastics market. The growing demand for better quality biopharma plastic equipment & components from hospitals in emerging economies like India, China, & Japan, driven by their growth in population & healthcare spending, has been an important factor driving the market growth in this region.
Further, North America is anticipated to witness high growth in terms of revenue in the coming future, which is due to the strong medical sector in the area, majorly in the United States which has been a major driver for the demand for biopharma plastics. The existence of major biopharma plastic manufacturers like Eastman Chemical Co., Celanese Corporation, & DuPont in the U.S. has also played a major role in driving the market forward in the nation.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
The biopharma plastics market is characterized by the presence of leading players, alongside a few medium and small regional companies. These major players are constantly engaged in developing advanced polymers to meet the higher demand for biopharma plastic components from the healthcare sector. The global biopharma plastics industry is known for its strong competition, mainly driven by the concentrated presence of major companies across different regions. These companies fiercely compete with each other and frequently engage in activities such as acquisitions, mergers, and collaborations.
Some of the prominent players in the Global Biopharma Plastics Market are
- SABIC
- BASF SE
- LG Chem
- Solvay
- Toray Industries, Inc.
- Dow, Inc.
- INEOS Group
- Tekni-Plex
- Formosa Plastics Corporation
- Covestro AG
- CHIMEI
- Other Key Players
Recent Developments
- In May 2024, ETERNAL and its sister projects, ENVIROMED, IMPACTIVE, SusPharma, and TransPharm, collaborated to develop a Green Pharma Horizon Projects Cluster and capitalize on synergistic development, which focuses on increasing the sustainability of pharmaceutical products & exploit research synergies to boost the impact of innovations.
- In January 2024, Bormioli Pharma and Loop Industries, Inc. announced that an innovative pharmaceutical packaging bottle manufactured with a completely recycled virgin quality Loop PET resin will be introduced within the Bormioli booth at Pharmapack Europe 2024.
- In August 2023, AIMPLAS, the Plastics Technology Centre, forms part of the BioICEP project, which is to develop sustainable and environmentally friendly alternatives to traditional petroleum-based plastics. The project used an innovative cascade process by applying & combining chemical and biological methods to turn fossil-based plastic waste into natural, biodegradable substitutes to be used in the packaging and pharma industries.
- In May 2023, DuPont unveiled that it has entered into a definitive agreement to acquire Spectrum Plastics Group from AEA Investors. The purchase price will be paid from existing cash balances and is expected to close by the end of the third quarter of 2023, subject to regulatory approvals & other customary closing conditions.
- In March 2023, DuPont introduced a series of high-quality products for value chain users in the biopharmaceutical industry, which includes new China-made silicone tubing allowing local material supply and meeting the rise in local demand. Further, DuPont Healthcare also announced the new Chinese brand name for Liveo Healthcare Solutions at the exhibition for the first time.
Report Details
| Report Characteristics |
| Market Size (2024) |
USD 6,240.0 MN |
| Forecast Value (2033) |
USD 18,310.3 MN |
| CAGR (2024-2033) |
12.4% |
| Historical Data |
2018 – 2023 |
| Forecast Data |
2024 – 2033 |
| Base Year |
2023 |
| Estimate Year |
2024 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Polymer Type (Polyethylene, Polypropylene, Polyethylene Terephthalate, Polyvinyl Chloride, Acrylonitrile Butadiene Styrene, Polycarbonate, Polytetrafluoroethylene, and Others), and By Application (Containers, Bioreactor bags, protective wear, Depth Filters, Syringes, Disposable Medical Connectors, and Others) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
SABIC, BASF SE, LG Chem, Solvay, Toray Industries, Inc., Dow, Inc., INEOS Group, Tekni-Plex, Formosa Plastics Corporation, Covestro AG, CHIMEI, and Other Key Players |
| Purchase Options |
HVMN Inc., Thync Global Inc., Apple Inc., Fitbit Inc., TrackmyStack, OsteoStrong, The ODIN, Thriveport LLC, Muse, Moodmetric, and Other Key Players |
Frequently Asked Questions
The Global Biopharma Plastics Market exhibited a strong performance in 2024, with a total value of USD 5,695.3 million.
The Global Biopharma Plastics Market is expected to increase by 12.4% during the forecasted period.
The Asia Pacific region will emerge as the dominant market for biopharma plastics, with a maximum share of 31.1% of total revenue, in 2024.
Some of the prominent key players in the Global Biopharma Plastics Market include SABIC, BASF SE, LG Chem, Solvay, Toray Industries, Inc., Dow, Inc., INEOS Group, and other key players.